Cell-based tissue repair of the tooth and -tooth-supporting -periodontal 
Introduction

Our understanding of tooth development and biology of tooth diseases has tremendously advanced in the past two decades. Tooth pathology occurs mainly as a result of periodontal disease or carious lesions. Recent insights on the reparative capability of periodontium and dental pulp in conjunction with progress in stem cell biology, molecular biology and material science will enable us to develop novel therapies using engineered biological compounds and cell based therapeutics. In order to achieve a dental engineering therapy it is necessary to address all the cells and tissues involved in the formation, maintenance and repair of the tooth. Resembling other epithelial appendages, the tooth develops from a series of epithelial/mesenchymal interactions.
Once formed the mesenchymal components of the tooth (dentine and periodontal ligament [PDL] ) persist and are capable of only limited repair in response to injury. Here we will explore how tissue engineering can take advantage of these repair processes enhancing them and achieve artificial but biological tooth repair. [1] . Preventive dental care reduces the setback of dental decay, but the problem persists. The only solution to tooth perish has been restorative prosthetics in the form of implants. Implant technology is indeed ancient, as the earliest known dental prosthetics dates back to 2500 BC in Egypt and the first known tooth replacement was documented from the Mayan culture in AD 600 [2] .
The need for tooth tissue engineering
One of the unwanted effects of increase longevity in the population is the increase of dentition decay. By the end of last century nearly 25% of the US population aged 65 to 75 years old had lost their
Despite the long history of dental implants there are still limitations in functionality and longevity of the implants mainly due to alveolar bone loss. The tooth organ interacts actively with the alveolar bone through the PDL. Implants lack the plasticity and the biological interactions with the bone that the natural tooth has. PDL biology and bioengineering have advanced tremendously addressing the problems with periodontal diseases and have attempted to alleviate the tooth implants side effects [3] . [4] , but these processes may be re-activated after injury. In the case of severe tooth lesions the spontaneous regenerative power of the periodontium or the dental pulp is often insufficient resulting in tooth lost. In these cases tissue engineering and regenerative medicine could find indication.
The hard tissues of the tooth's crown provide a barrier against bacteria. When a traumatic injury or a carious lesion breaks down this barrier, repair takes place to prevent invasion of the pulp chamber by bacteria. The capacity for pulp cells to resist and repair injuries is fundamental for the maintenance of tooth integrity and homeostasis. In the adult pulp, cell division and the secretory activity of odontoblasts are limited
Cellular components and development of tooth
The usage of stem cells systems as a tool for tissue engineering has great potential. Stem cell research has resulted in many clinical applications. Examples of cell based therapies include repair of skin [5] , bone [6, 7] , articular cartilage [8] , cardiac tissues [9, 10] and neuronal tissue in Parkinson's disease [11, 12] [72] [73] [74] . Of note, last year the first clinical application for alveolar bone reconstruction using DPSCs was successfully carried out in a patient [75] .
The clinical application of DPSCs in regeneration of the pulp/dentin complex
Dental caries is a very common oral disease. It is essentially an infection of the mineral tissues of the tooth, which eventually
reaches the dental pulp of the tooth causing inflammation and potentially tooth loss. The dental pulp has important functions to provide nutrients, oxygen and nerve supply to the tooth. In addition, a crucial property of the dental pulp is to foster cells of the immune system that would tackle the infection, and to produce reactionary or reparative dentin formation in response to external stimuli, including bacterial invasion [76] [77] [78] [90, 91] . It was concluded that the PDL tissue has the regenerative capacity and can form not only the interconnecting collagen tissue, but also alveolar bone and cementum [92] [93] [94] . From these early observations, it was concluded that the PDL tissue contains progenitor cells for fibroblasts, osteoblasts and cementoblasts [95] . Several studies demonstrated that PDL from mouse molars contains a slowly dividing population of progenitor cells that is located in perivascular sites [96, 97] , as well as in the periosteal and endosteal spaces of the alveolar bone [98] . It was further demonstrated that PDL contains renewable and differentiated populations of cells [99, 100] [102] . [109] .
In vitro studies have also found that PDLSCs were capable of differentiating into mesodermal (i.e. adipocytes, osteoblasts, chondrocytes), ectodermal (i.e. neurons), and endodermal (i.e. hepatocytes) lineages [103]. In addition, rat PDLSCs have the capacity to differentiate into vascular cells forming blood vessellike structures [104]. These findings suggest that the PDL constitutes an important stem cell source not only for the regeneration of periodontal tissues [105], but also for the regeneration of other tissues and organs. Despite the strong promise that PDL holds for regenerative clinical dentistry, there is a however need for further characterization of the PDLSCs. Gingiva is the oral mucosal tissue that surrounds the teeth and covers the alveolar bone. It functions as a protective mechanical barrier for the tooth supporting tissues and as a biological barrier conferring distinct immunity to oral infection. It is composed of an epithelial layer with an underlying vasculated connective tissue. As the epithelial layer has the capacity for continuous renewal, it is anticipated that this tissue could be a source of stem cells. Cells with mesenchymal stem cell properties have recently been isolated from gingival tissues and characterized [106-108]. These cells have unique immunomodulatory functions, clonogenicity, as well as self-renewal and multi-potent differentiation capacities. Very recently gingival fibroblasts have been evaluated as source of iPS cells. These cells gave rise to high-quality iPS cells suggested that gingival fibroblasts could be promising for cellular reprogramming and pluripotency for future clinical applications
The root cementum is an avascular and unnerved mineralized tissue with ultrastructural similarity to bone that covers the entire root surface. It is the interface between the dentinal tissue and the PDL and contributes to periodontal tissue repair and regeneration after damage. The organic extracellular matrix of cementum contains proteins that selectively enhance the attachment and proliferation of cell populations residing within the PDL space [110] [111] [112] [113] [114] . Human cementum-derived cells have been isolated, cloned and characterized in vitro and in vivo [115] . When transplanted subcutaneously in immunodeficient mice, the mineralized matrix produced by these cells exhibited several features identical to cementum, and differed from the mineralized matrix produced by human bone marrow stromal cells [116] . [117] . The periosteum is also considered as a suitable cell source for bone regeneration [118] [119] [120] [121] .
The alveolar bone is a part of the periodontal tissues, functioning as an anchorage of the tooth root to the alveoli and resorbing the forces generated by the function of mastication. Progenitor cells which are responsible for alveolar bone formation lay in the periosteal region, the PDL or around the blood vessels. Alveolar bone marrow is considered as a useful and easily accessible source of progenitor cells, as they have similar osteogenic potential to those derived from the iliac crest
Past, current and future approaches in periodontal regeneration
Periodontal disease is perhaps the most common infectious disease in human beings caused by bacteria present in the oral cavity, which attach on the teeth and cause inflammation of the periodontal tissues. Epidemiological studies show that approximately 7-13% of the global population is at high risk of developing severe forms of destructive periodontitis [122], posing a tremendous burden to health care. This creates a need to develop new therapies directed at the attenuation of the disease and regeneration of the lost tissues, including the PDL and alveolar bone. Periodontal regeneration is defined as reproduction or reconstruction of a functional attachment apparatus consisting of new cementum, alveolar bone and PDL, on a root surface that was previously exposed due to progression of periodontitis.
Early regeneration approaches have focused on providing appropriate conditions for wound healing. These included a range of surgical procedures along with use of bone grafts as tissue substitutes, barrier membranes to prevent the unfavourable tissues from the healing area [92, 123, 124] , and more lately, growth factors as means to induce the wound healing capacity of the remaining tissue. One of the very early approaches for regeneration of the lost periodontal tissues was mechanical or surgical removal of the diseased tissues [125, 126] [135] [136] [137] [138] . These studies concluded that PDGF alone or in combination with the other growth factors seem to have a positive effect on periodontal healing and regeneration.
Molecular mechanisms and factors regulating regeneration of periodontal tissues
Predictable periodontal tissue regeneration needs to ideally recapitulate embryonic development, following similar morphogenetic gene expression patterns. Although it is evident that there are many factors that may prove important for controlling periodontal tissue formation, this section focuses on the growth factors and enamel matrix proteins with a proven role in controlling the behaviour of cells within the periodontal tissues. The principle of therapeutic application of growth factors for the restoration of damaged tissues is based on adult tissue regeneration by mimicking the processes of embryonic and post-natal development [131-134]. The most studied growth factors for periodontal regeneration have been platelet-derived growth factor (PDGF), epidermal growth factor (EGF), FGF, IGF and different BMPs. The PDGF members has been extensively evaluated in both in vitro and in vivo
Another promising group of growth factors is the BMP family, consisting of members of the TGF-␤ superfamily. These secretory signal molecules have a variety of functions during morphogenesis and cell differentiation [139] [140] [141] . A wide body of evidence from periodontal regeneration studies indicate that BMPs are capable of inducing formation of new alveolar bone and cementum [141] [142] [143] . However, because classic BMPs induce the differentiation of cells along an osteogenic pathway, ankylosis can be a frequent side-effect, characterized by the absence of the mediating PDL between the alveolar bone and cementum [144] . Hence, BMPs have not yet been approved for periodontal applications and further experimentation is needed for improving the capacity for periodontal regeneration.
Amelogenins are proteins secreted by ameloblasts and are considered to play a major role in regulating formation of enamel [145] . The rationale for the potential use of enamel proteins in periodontal tissue regeneration therapies is justified by their presence in initial cementum formation, during normal development of the tooth attachment apparatus [146, 147] . The commercially available enamel matrix protein product namely, Emdogain (Straumann AG, Basel, Switzerland), has been in the market for over a decade now [148, 149] . This is a purified acid extract of proteins containing predominantly amelogenin from pig enamel matrix. A large number of studies have investigated the mechanisms of action and clinical efficiency of Emdogain [131, 146, [150] [151] [152] [153] [142, [154] [155] [156] [157] [158] [159] . Along with clinical and experimental animal confirming the clinical efficiency of Emdogain in periodontal regeneration procedures [158, 160, 161] , recent systematic reviews are also in support of these findings [162] [163] [164] 
Scaffolding and material science
The use of scaffolds in tooth repair has been extensively used and studied. Scaffolds are particularly useful when a 3D structure is needed (Fig. 3) [167, 168] . These emerging technologies on material science offer bio-printing as an alternative way of creating 3D structures useful for tissues engineering and should be closely follow. 
